Evotec SE EVO
NASDAQ EVO
$1.43 +0.09 (+6.69%)
As of: Oct 14, 2026 · 11:49 AM EDT

Evotec SE (EVO) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Evotec SE (EVO) recorded Liabilities and Shareholders Equity of $1.83 billion in the quarter ended Jun 30, 2026, down 10.6% from $2.05 billion a year earlier and down 4.7% from the prior quarter.

Analysis

Evotec SE (EVO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Evotec SE reported Liabilities and Shareholders Equity of $1.94 billion, down 6.5% from the prior year.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 3.0% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $2.07 billion in the year ended Dec 31, 2024 (-15.0%), $2.44 billion in the year ended Dec 31, 2023 (+2.4%), $2.38 billion in the year ended Dec 31, 2022 (-10.1%) and $2.65 billion in the year ended Dec 31, 2021 (+58.4%).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Liabilities and Shareholders Equity since the quarter ended Dec 31, 2020.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined for four consecutive quarters, with an average decline of 9.1% over the last six quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 46.7% in the quarter ended Dec 31, 2021, against a decline of 15.7% in the quarter ended Dec 31, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.92 billion (quarter ended Mar 31, 2026), $2 billion (quarter ended Dec 31, 2025) and $2.07 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Iqvia Holdings 43.61 Bn 35.31 Bn 1.44 Bn 29.88 Bn
2 Medpace Holdings 17.32 Bn 15.38 Bn 201.64 Mn 2.06 Bn
3 Charles River Laboratories International 14.52 Bn 13.72 Bn 363.37 Mn 7.53 Bn
4 Icon 13.20 Bn 10.31 Bn 479.29 Mn 16.40 Bn
5 Fortrea Holdings 2.04 Bn 1.42 Bn 139.20 Mn 2.71 Bn
6 Ginkgo Bioworks Holdings 725.88 Mn -36.20 Mn 18.44 Mn 990.05 Mn
7 Evotec SE 509.65 Mn -1.10 Bn - 1.80 Bn
8 Champions Oncology 67.26 Mn 42.35 Mn 7.70 Mn 33.29 Mn
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn 12.36 Mn
10 Natural Alternatives International 6.69 Mn -21.39 Mn 1.73 Mn 126.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.80 Bn
Mar 31, 2026 1.88 Bn
Dec 31, 2025 2.01 Bn
Sep 30, 2025 2.08 Bn
Jun 30, 2025 2.12 Bn
Mar 31, 2025 2.11 Bn
Dec 31, 2024 1.99 Bn
Sep 30, 2024 2.22 Bn
Mar 31, 2024 2.38 Bn
Dec 31, 2023 2.49 Bn
Jun 30, 2023 2.50 Bn
Dec 31, 2022 2.41 Bn
Sep 30, 2022 2.22 Bn
Mar 31, 2022 2.44 Bn
Dec 31, 2021 2.53 Bn
Sep 30, 2021 2.05 Bn
Dec 31, 2020 1.80 Bn
Dec 31, 2019 12.84 Mn
Sep 30, 2010 242.85 Mn
Jun 30, 2010 185.15 Mn
API Access

Evotec SE Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EVO&period=max&api_key=YOUR_API_KEY